A Multiple Ascending Dose Trial of CVL-231 in Subjects With Schizophrenia
Clinical trial NCT04136873 · COMPLETED
Trial details
- NCT number
- NCT04136873
- Sponsor
- Cerevel Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-15
- Primary completion
- 2021-05-07
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.